Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2019

Open Access 01-12-2019 | Adenocarcinoma of the Esophagogastric Junction | Research article

Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction

Authors: Qifan Yin, Wenhao Wang, Huining Liu, Guang Yang, Shaohui Zhou, Lijun Liu

Published in: Journal of Cardiothoracic Surgery | Issue 1/2019

Login to get access

Abstract

Background

The surgical approach (transthoracic or transabdominal) for patients with Siewert type II adenocarcinoma of the esophagogastric junction (AEG) still remains controversial. We made a bold attempt to adopt the modified Ivor-Lewis surgery, No turning over, thoraco-laparoscopic esophagogastrectomy, two-field lymphadenectomy and intrathoracic anastomosis, to observe the clinical application and effect.

Method

Data of patients with Siewert type II AEG were collected in the Hebei General Hospital from June 2017 to February 2019. The operation time, surgical blood loss, the number of dissected lymph nodes, duration of drainage tube, postoperative complications, the length of postoperative hospital stay were collected to assess the safety and feasibility of modified Ivor-Lewis surgery.

Results

A total of 20 patients with Siewert type II AEG were analyzed in our research, there was no case of turning to thoracotomy, laparotomy or death during the operation.The average operation time, surgical blood loss, amount of dissected lymph nodes, duration of drainage tube, postoperative hospital stay of all enrolled patients was 4.67, 0.57 h, 156, 56.80 ml, 22.55, 3.91, 8.6, 2.21 days, 12.85, 2.5 days respectively. Among all the enrolled patients, one patient(5%) developed anastomotic fistula and one patient(5%) developed hematemesis after operation, eventually, these two patients were discharged successfully.

Conclusion

For patients with Siewert type II AEG, The modified Ivor-Lewis surgery, No turning over, thoraco-laparoscopic esophagogastrectomy, two-field lymphadenectomy and intrathoracic anastomosis, is safe and feasible. The feasibility and safety could be further and better investigated with a RCT to achieve more conclusive results.
Literature
1.
go back to reference Hasegawa S, Yoshikawa T. Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Gastric Cancer. 2010;13:63–73.CrossRef Hasegawa S, Yoshikawa T. Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Gastric Cancer. 2010;13:63–73.CrossRef
2.
go back to reference Szántó I, Vörös A, Gonda G, et al. Siewert-Stein classification of adenocarcinoma of the esophagogastric junction. Magy Seb. 2001;54:144–9.PubMed Szántó I, Vörös A, Gonda G, et al. Siewert-Stein classification of adenocarcinoma of the esophagogastric junction. Magy Seb. 2001;54:144–9.PubMed
3.
go back to reference Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol. 2006;7:644–51.CrossRef Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol. 2006;7:644–51.CrossRef
4.
go back to reference Ott K, Bader FG, Lordick F, et al. Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an exper ienced center. Ann Surg Oncol. 2009;16:1017–25.CrossRef Ott K, Bader FG, Lordick F, et al. Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an exper ienced center. Ann Surg Oncol. 2009;16:1017–25.CrossRef
5.
go back to reference Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg. 1999;230:392–400 discussion 400-393.CrossRef Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg. 1999;230:392–400 discussion 400-393.CrossRef
6.
go back to reference Ajani JA, D'Amico TA, Almhanna K, et al. Gastric Cancer, version 3.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2016;14:1286–312.CrossRef Ajani JA, D'Amico TA, Almhanna K, et al. Gastric Cancer, version 3.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2016;14:1286–312.CrossRef
7.
go back to reference Stahl M, Mariette C, Haustermans K, et al. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi51–6.CrossRef Stahl M, Mariette C, Haustermans K, et al. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi51–6.CrossRef
8.
go back to reference Porschen R, Buck A, Fischbach W, et al. S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des ?sophagus (La ngversion 1.0 - September 2015, AWMF-Registernummer: 021/023OL). Z Gastroenterol. 2015;53:1288–347.CrossRef Porschen R, Buck A, Fischbach W, et al. S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des ?sophagus (La ngversion 1.0 - September 2015, AWMF-Registernummer: 021/023OL). Z Gastroenterol. 2015;53:1288–347.CrossRef
9.
go back to reference Kodama I, Kofuji K, Yano S, et al. Lymph node metastasis and lymphadenectomy for carcinoma in the gastric cardia: clinical experience. Int Surg. 1998;83:205–9.PubMed Kodama I, Kofuji K, Yano S, et al. Lymph node metastasis and lymphadenectomy for carcinoma in the gastric cardia: clinical experience. Int Surg. 1998;83:205–9.PubMed
10.
go back to reference Yonemura Y, Tsugawa K, Fonseca L, et al. Lymph node metastasis and surgical management of gastric cancer invading the esophagus. Hepatogastroenterology. 1995;42:37–42.PubMed Yonemura Y, Tsugawa K, Fonseca L, et al. Lymph node metastasis and surgical management of gastric cancer invading the esophagus. Hepatogastroenterology. 1995;42:37–42.PubMed
11.
go back to reference Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.CrossRef Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.CrossRef
12.
go back to reference Pedrazzani C. Should adenocarcinoma of the esophagogastric junction be classified as gastric or esophageal cancer, or else as a distinct clinical entity? Ann Surg. 2015;261:e107–8.CrossRef Pedrazzani C. Should adenocarcinoma of the esophagogastric junction be classified as gastric or esophageal cancer, or else as a distinct clinical entity? Ann Surg. 2015;261:e107–8.CrossRef
13.
go back to reference Kurokawa Y, Takiguchi S, Mori M, Doki Y. Surgery for esophagogastric junction tumor. Nihon Shokakibyo Gakkai Zasshi. 2015;112:1785–90. Kurokawa Y, Takiguchi S, Mori M, Doki Y. Surgery for esophagogastric junction tumor. Nihon Shokakibyo Gakkai Zasshi. 2015;112:1785–90.
Metadata
Title
Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction
Authors
Qifan Yin
Wenhao Wang
Huining Liu
Guang Yang
Shaohui Zhou
Lijun Liu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2019
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-019-1023-7

Other articles of this Issue 1/2019

Journal of Cardiothoracic Surgery 1/2019 Go to the issue